ArticlePediatric blood & cancer2009

Phase I study of SU5416, a small molecule inhibitor of the vascular endothelial growth factor receptor (VEGFR) in refractory pediatric central nervous system tumors.

Mark W Kieran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.